JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
SPX Corp
SPXC
$8.67B
| $4.41M | ﹤0.01% |
83,386
+19,334
| +30% | +$933K |
2013 Q2
36 quarters
|
|
2752
CALL
Corning
GLW
$141B
| $4.4M | ﹤0.01% |
139,600
| – | – |
2021 Q3
3 quarters
|
|
2753
Invesco S&P 500 Top 50 ETF
XLG
$11.8B
| $4.4M | ﹤0.01% |
153,480
+11,330
| +8% | +$353K |
2013 Q2
36 quarters
|
|
2754
Resources Connection
RGP
$134M
| $4.4M | ﹤0.01% |
215,844
+130,737
| +154% | +$2.33M |
2013 Q2
36 quarters
|
|
2755
ASE Group
ASX
$124B
| $4.4M | ﹤0.01% |
850,208
+38,040
| +5% | +$253K |
2013 Q2
36 quarters
|
|
|
TETC
2756
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
| $4.39M | ﹤0.01% |
448,999
-50,001
| -10% | -$489K |
2021 Q4
2 quarters
|
|
2757
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.25B
| $4.38M | ﹤0.01% |
125,931
-5,930
| -4% | -$218K |
2015 Q1
29 quarters
|
|
2758
CBIZ
CBZ
$3B
| $4.38M | ﹤0.01% |
109,679
-24,450
| -18% | -$988K |
2013 Q2
36 quarters
|
|
2759
State Street SPDR S&P Pharmaceuticals ETF
XPH
$525M
| $4.38M | ﹤0.01% |
104,298
+43,959
| +73% | +$1.84M |
2015 Q4
26 quarters
|
|
|
VIA
2760
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $4.38M | ﹤0.01% |
114,338
-52,244
| -31% | -$2.05M |
2014 Q4
30 quarters
|
|
2761
Genworth Financial
GNW
$3.61B
| $4.38M | ﹤0.01% |
1,240,482
-319,101
| -20% | -$1.22M |
2013 Q2
36 quarters
|
|
2762
Fidelity MSCI Information Technology Index ETF
FTEC
$22.5B
| $4.37M | ﹤0.01% |
45,313
+36,257
| +400% | +$3.86M |
2015 Q4
26 quarters
|
|
2763
AbCellera Biologics
ABCL
$4.45B
| $4.37M | ﹤0.01% |
410,104
+259,222
| +172% | +$2.19M |
2021 Q4
2 quarters
|
|
2764
Lucid Motors
LCID
$1.63B
| $4.37M | ﹤0.01% |
25,439
+12,874
| +102% | +$2.45M |
2020 Q3
7 quarters
|
|
2765
Star Bulk Carriers
SBLK
$3.57B
| $4.36M | ﹤0.01% |
174,626
+44,048
| +34% | +$1.28M |
2017 Q3
19 quarters
|
|
|
DDL
2766
Dingdong
DDL
$470M
| $4.35M | ﹤0.01% |
+787,338
| New | +$3.88M |
2022 Q2
0 quarters
|
|
2767
Pegasystems
PEGA
$5.58B
| $4.35M | ﹤0.01% |
181,874
+104,044
| +134% | +$3.11M |
2013 Q2
36 quarters
|
|
2768
Autoliv
ALV
$8.19B
| $4.35M | ﹤0.01% |
60,759
+38,413
| +172% | +$2.87M |
2013 Q2
36 quarters
|
|
|
AZEK
2769
DELISTED
The AZEK Co
AZEK
| $4.34M | ﹤0.01% |
259,228
-2,425,457
| -90% | -$49.8M |
2020 Q2
8 quarters
|
|
2770
iShares Morningstar Value ETF
ILCV
$1.32B
| $4.33M | ﹤0.01% |
71,724
-900
| -1% | -$58.3K |
2016 Q1
25 quarters
|
|
|
CDR
2771
DELISTED
Cedar Realty Trust, Inc
CDR
| $4.33M | ﹤0.01% |
150,434
-246,762
| -62% | -$6.75M |
2013 Q2
36 quarters
|
|
2772
Hecla Mining
HL
$11.6B
| $4.33M | ﹤0.01% |
1,103,473
+104,858
| +11% | +$545K |
2015 Q4
26 quarters
|
|
2773
ImmunityBio
IBRX
$10.9B
| $4.32M | ﹤0.01% |
1,161,894
-27,269
| -2% | -$110K |
2015 Q3
27 quarters
|
|
|
MTOR
2774
DELISTED
MERITOR, Inc.
MTOR
| $4.32M | ﹤0.01% |
118,905
-255,870
| -68% | -$9.2M |
2014 Q3
31 quarters
|
|
2775
CALL
Hartford Financial Services
HIG
$34.1B
| $4.32M | ﹤0.01% |
+66,000
| New | +$4.63M |
2022 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.